Disease: Hemorrhagic thrombocythemia (Essential Thrombocythemia)
- A 1-year-old child with essential thrombocythemia
- A 27-Year-Old Female With JAK2 Mutation: A Case of Budd-Chiari Syndrome Secondary to Prolonged Oral Contraceptive Pill Use
- A Case Report on the Utilization of a Hemostasis Analyzer System in the Management of a Patient With Essential Thrombocythemia
- A rare case of essential thrombocythemia with pseudo-hyperkalemia
- A Rare Coexistence of Smoldering Multiple Myeloma and JAK2-Positive Myeloproliferative Neoplasm: A Case of Dual Synchronous Hematological Malignancy
- A Review About the Assessment of the Bleeding and Thrombosis Risk for Patients With Myeloproliferative Neoplasms Scheduled for Surgery
- A thromboembolic event as the first presentation of essential thrombocytosis: A case report
- Acquired von Willebrand Syndrome in a 17-Year-Old With Essential Thrombocythemia: A Case Report With Literature Review
- Acute invasive fungal sinusitis with orbital tip syndrome in patients on long-term use of ruxolitinib: a case report
- Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review
- ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms
- Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision Medicine
- An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
- Analysis of CHIP-Related Mutation and Risk of Cardio-Cerebrovasculars Events in Patients with Myeloproliferative Neoplasms
- Analysis of the factors influencing the severity of coronavirus disease 2019 in patients with myeloproliferative neoplasms based on an online questionnaire
- Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies
- Aspirin use in essential thrombocythemia: Once-daily or twice-daily or not at all?
- Assessment of Total Antioxidant Capacity, 8-Hydroxy-2'-deoxy-guanosine, the Genetic Landscape, and Their Associations in <em>BCR::ABL-1</em>-Negative Chronic and Blast Phase Myeloproliferative Neoplasms
- Bleeding heralding the diagnosis of essential thrombocythemia
- Broad next generation integrated sequencing of myelofibrosis identifies disease-specific and age-related genomic alterations
- C-Mannosyl tryptophan is a novel biomarker for thrombocytosis of myeloproliferative neoplasms
- CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia
- CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM
- Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
- Calreticulin-Enigmatic Discovery
- Case report: Effectiveness of low-dose methotrexate monotherapy in post-essential thrombocythemia myelofibrosis
- Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome
- Childbirth rates in women with myeloproliferative neoplasms
- Chronic myeloproliferative neoplasms with concomitant <em>CALR</em> mutation and <em>BCR::ABL1</em> translocation: diagnostic and therapeutic implications of a rare hybrid disease
- Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea
- Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia
- Clonal evolution process from essential thrombocythemia to acute myeloid leukemia in the original patient from whom the CALR-mutated Marimo cell line was established
- Co-occurrence of <em>JAK2-V617 F</em> mutation and <em>BCR::ABL1</em> translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination
- Comparison of Clinical Characteristics of JAK2, CALR and Tri-Negative Driving Mutant Type in Patients with Essential Thrombocythemia
- Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression
- Correction: A Young Adult With Essential Thrombocythemia Presenting as Myocardial Infarction
- Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p/caspase3 axis
- Detecting Multiple Driver Mutations in a Patient with Essential Thrombocythemia
- Diagnosis and Therapy in MCT8 Deficiency: Ongoing Challenges
- Digital gangrene: can be the first manifestation of essential thrombocythemia? a case report
- Direct and indirect costs for patients with myeloproliferative neoplasms
- Essential thrombocythemia with MPL W515S mutation
- Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management
- Essential thrombocythemia: nutritional management in weight loss and malnutrition
- Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis
- Exploring hematological alterations and genetics linked to SNV rs10974944 in myeloproliferative neoplasms among Amazon patients
- Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology
- Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms
- Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients
- Inflammation as a cause of acute myocardial infarction in patients with myeloproliferative neoplasm
- Initial Low-Dose Hydroxyurea and Anagrelide Combination in Essential Thrombocythemia: Comparable Response with Lower Toxicity
- Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia
- Interferons in the treatment of myeloproliferative neoplasms
- Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosis
- Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial
- Management of Essential Thrombocythemia in a Patient With a History of Thrombotic Thrombocytopenic Purpura
- Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post-essential thrombocythemia myelofibrosis: A case report
- Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements
- Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis
- Myelofibrosis: Current unmet needs, emerging treatments, and future perspectives
- Myeloproliferative Neoplasms Transcriptome Reveals Pro-Inflammatory Signature and Enrichment in Peripheral Blood Monocyte-Related Genes
- Near-early T-cell precursor acute lymphoblastic leukemia following a diagnosis of essential thrombocythemia
- Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study
- Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms
- Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia
- Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach
- Polyglobulie essentielle et hypertension portale non cirrhotique diagnostiquées en cours de grossesse
- Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis
- Presence and Onset of Chronic Kidney Disease as a Factor Involved in the Poor Prognosis of Patients with Essential Thrombocythemia
- Pseudo-lymphocytosis caused by circulating megakaryocyte fragments in a patient with post-essential thrombocythemia myelofibrosis
- Queries regarding the two papers each reporting on 1000 essential thrombocythemia patients in BCJ
- Raman Spectroscopy of Blood Serum for Essential Thrombocythemia Diagnosis: Correlation with Genetic Mutations and Optimization of Laser Wavelengths
- Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores
- Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
- Recent findings and advances in treatment of myeloproliferative neoplasms
- Recombinant interferon alfa in BCR/ABL-negative chronic myeloproliferative neoplasms
- Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia
- Relationship between DTA Mutations and Thromboembolism in Patients with Myeloproliferative Neoplasms
- Renal tubular necrosis associated with anagrelide administration: a case report
- Repeated Ischemic Stroke due to in situ Thrombus at the Middle Cerebral Artery in a Patient with Essential Thrombocythemia
- Resveratrol and tetrahydroisoquinoline effects on neutrophil sensitivity to NETosis formation in low-risk essential thrombocythemia patients
- Retinal Vessel Analysis and Microvascular Abnormalities in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
- Risk factors for ischemic stroke in patients with Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms
- Risk of thrombosis, hemorrhage and leukemic transformation in patients with myeloproliferative neoplasms: A nationwide longitudinal cohort study
- ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
- Sailing in deceptive calm: Navigating the undercurrents of essential thrombocythaemia
- Sex-specific impact on disease outcome and the mutational landscape in essential thrombocythemia: A retrospective cohort study
- SOHO State of the Art Updates and Next Questions | Diagnosis, Outcomes, and Management of Prefibrotic Myelofibrosis
- Study of significance of bone marrow microvessel density in myeloproliferative neoplasms in correlation with CD34 blasts, mast cell count and fibrosis
- Successful management of VTE with essential thrombocythemia and cavernous transformation of the portal vein in early pregnancy: a case report
- The Burden of symptoms and Quality of life of Filipino patients with Myeloproliferative neoplasm: A Multicenter Cross-sectional survey
- The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms
- The evolutionary journey from essential thrombocythaemia to acute erythroid leukaemia
- The Role of DNA Repair (<em>XPC</em>, <em>XPD</em>, <em>XPF</em>, and <em>XPG)</em> Gene Polymorphisms in the Development of Myeloproliferative Neoplasms
- Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events
- Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Myeloproliferative Neoplasms
- Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis
- Transformation into acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 from JAK2-mutated essential thrombocythemia: a case report
- Translation, Cultural Adaptation, and Validation into Romanian of the Myeloproliferative Neoplasm Symptom Assessment Form-Total Symptom Score (MPN-SAF TSS or MPN-10) Questionnaire
- Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study